Holdings: Assessment of Governance and Corruption in the Pharmaceutical Sector : Lessons Learned from Low and Middle Income Countries

Assessment of Governance and Corruption in the Pharmaceutical Sector : Lessons Learned from Low and Middle Income Countries

Pharmaceuticals are a critical input for the health sector. At the same time, the drug business sustains many individual and corporate livelihoods and produces handsome returns for those involved in the trade. Good governance is critical for the se...

Full description

Bibliographic Details
Main Authors:	Diack, Aissatou, Seiter, Andreas, Hawkins, Loraine, Dweik, Imad Subhi
Language:	English en_US
Published:	World Bank, Washington, DC 2013
Subjects:	ABUSE ACCESS TO PHARMACEUTICALS ACCOUNTABILITY ANTIBIOTICS ASSASSINATION AUTHORITY BIDDING BRAND BRANDS BUDGETING CAPACITY BUILDING CASH FLOW CENTRAL GOVERNMENT CENTRAL GOVERNMENT AUTHORITIES CENTRAL MEDICAL STORES CITIZENS CLINICS COMMODITIES COMMUNICABLE DISEASES COMMUNITY HEALTH CONTRACEPTIVES CONTRACTING OUT CORRUPTION CRIME DECISION MAKERS DECISION-MAKING DECREE DEVELOPMENT GOALS DIABETES DIET DISPENSING FEES DISTRICTS DRUG FINANCING DRUG FORMULARIES DRUG PRESCRIBING DRUG PRICES DRUG TESTING DRUG UTILIZATION DRUGS EFFECTIVE GOVERNANCE EFFICIENT MARKET ENFORCEMENT ACTION ESSENTIAL DRUGS ESSENTIAL MEDICINES EXPENDITURE EXPENDITURE EXPENDITURE MANAGEMENT EXPENDITURES FEASIBILITY FEASIBILITY STUDY FIELD TESTING FINANCIAL INCENTIVES FINANCIAL MANAGEMENT FINANCIAL RESOURCES FRAUD GENERIC DRUGS GENERIC PRODUCTS GMP GOOD GOVERNANCE GOVERNMENT DECISION GOVERNMENT PROGRAMS GOVERNMENTAL ORGANIZATION HEALTH CARE HEALTH CARE WORKERS HEALTH FACILITIES HEALTH INSURANCE HEALTH MANAGEMENT HEALTH OUTCOMES HEALTH SECTOR HEALTH SERVICES HEALTH SYSTEM HEALTH SYSTEMS HEALTH WORKERS HEALTHCARE PROVIDERS HORMONES HOSPITALS HUMAN DEVELOPMENT HUMAN DEVELOPMENT NETWORK IMPORTED DRUGS INDICATOR DRUGS INFORMAL SECTOR INSTITUTIONAL CAPACITY INSURANCE SCHEMES INTERVENTION INVENTORY INVENTORY CONTROL INVENTORY MANAGEMENT IRRATIONAL USE LABORATORIES LACK OF COMPETITION LAWS LEGAL ACTION LEGAL SYSTEM LEGISLATION LOCAL AUTHORITIES LOCAL GOVERNMENT LOCAL GOVERNMENTS LOCAL MANUFACTURERS LOW-INCOME COUNTRIES LOW-INCOME COUNTRY MALARIA MANAGEMENT SYSTEMS MARKET ACCESS MARKET FAILURE MARKET FAILURES MARKET SEGMENTS MARKET SHARE MARKETING MARKETIZATION MARKETPLACE MEDICAL STORES MEDICATION MEDICINE MEDICINES MILLENNIUM DEVELOPMENT GOALS MINISTRY OF HEALTH MONOPOLY NATIONAL DRUG NATIONAL POLICY NATIONS NUTRITION PATENTS PATIENT PATIENTS PAYMENT TERMS PERIPHERAL HEALTH FACILITIES PHARMACEUTICAL PHARMACEUTICAL EXPENDITURE PHARMACEUTICAL INDUSTRY PHARMACEUTICAL INSPECTORS PHARMACEUTICAL LAW PHARMACEUTICAL MANAGEMENT PHARMACEUTICAL POLICY PHARMACEUTICAL PRICING PHARMACEUTICAL PRICING POLICIES PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLY PHARMACEUTICAL SUPPLY CHAINS PHARMACEUTICALS PHARMACEUTICALS MANAGEMENT PHARMACEUTICALS REGULATION PHARMACIES PHARMACISTS PHARMACY POLICY DECISIONS POLICY DIALOGUE POLICY LEVEL POLICY MAKERS POLITICAL SUPPORT POOLED PROCUREMENT POOR GOVERNANCE PRESCRIPTIONS PRICE CEILINGS PRICE COMPARISONS PRICE COMPETITION PRICE CONTROL PRICE LEVELS PRICE LISTS PRICING MECHANISMS PRICING POLICY PRIVATE PHARMACIES PRIVATE SECTOR INVESTMENT PROCUREMENT PRODUCT QUALITY PROGRESS PUBLIC EDUCATION PUBLIC EXPENDITURE PUBLIC EXPENDITURES PUBLIC FUNDING PUBLIC FUNDS PUBLIC HEALTH PUBLIC HOSPITALS PUBLIC OFFICIALS PUBLIC PROCUREMENT PUBLIC RESOURCES PUBLIC SECTOR PUBLIC SERVICE PUBLIC SPENDING PUBLIC SYSTEM PURCHASING PURCHASING POWER QUALITY ASSURANCE QUALITY CONTROL RATIONAL DRUG USE RATIONAL USE OF DRUGS REBATES REFUGEES REGULATORY AGENCIES REGULATORY AGENCY REGULATORY AUTHORITIES REGULATORY AUTHORITY REGULATORY FRAMEWORK REGULATORY OVERSIGHT REGULATORY SYSTEM REPRESENTATIVES RETAIL RETAIL PHARMACIES RULE OF LAW SALE SALES SECURE SUPPLY SERVICE DELIVERY SKILLED STAFF SMOKING SOCIAL DEVELOPMENT SOCIAL HEALTH INSURANCE SOCIAL INSURANCE STANDARD TREATMENT GUIDELINES STOCKS SUBSTITUTION SUPPLIER SUPPLIERS SUPPLY CHAIN SUPPLY CHAIN MANAGEMENT SUPPLY SYSTEMS TECHNICAL ASSISTANCE TENDERING THERAPIES TRADITIONAL MEDICINES TRANSPARENCY TRANSPORT COSTS VACCINES VULNERABILITY WAREHOUSES WASTE WHOLESALER WHOLESALERS WORKERS
Online Access:	http://documents.worldbank.org/curated/en/2010/01/11809041/assessment-governance-corruption-pharmaceutical-sector-lessons-learned-low-middle-income-countries http://hdl.handle.net/10986/13614

Internet

http://documents.worldbank.org/curated/en/2010/01/11809041/assessment-governance-corruption-pharmaceutical-sector-lessons-learned-low-middle-income-countries
http://hdl.handle.net/10986/13614

Assessment of Governance and Corruption in the Pharmaceutical Sector : Lessons Learned from Low and Middle Income Countries

Internet

Similar Items